Literature DB >> 12637489

Adjuvant chemotherapy for node-positive breast cancer patients: which is the reference today?

Pierre Fumoleau, Jacques Bonneterre, Elisabeth Luporsi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12637489     DOI： 10.1200/JCO.2003.99.223

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Sequential docetaxel as adjuvant chemotherapy for node-positive or/and T3 or T4 breast cancer: clinical outcome (Mansoura University).

Authors:  H Sakr; R H Hamed; A H Anter; T Yossef
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

2.  FADD phosphorylation is critical for cell cycle regulation in breast cancer cells.

Authors:  S Matsuyoshi; K Shimada; M Nakamura; E Ishida; N Konishi
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

3.  Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.

Authors:  P Kerbrat; H Roché; J Bonneterre; C Veyret; A Lortholary; A Monnier; P Fumoleau; P Fargeot; M Namer; P Chollet; M-J Goudier; B Audhuy; H Simon; P Montcuquet; J-C Eymard; S Walter; P Clavère; J-P Guastalla
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.